BioWorld Asia

Sep. 12, 2007

View Archived Issues

Swedish Study Finds Molecular Cause For Kidney Infections

Aptuit Paying $64M For Evotec Chemistry Unit

Antisoma's Lung Cancer Drug Repeats Strong Phase II Results

Biotech Fears Tough Restrictions From EU On Use of Primates

Nanobody Alliance With BI Could Net €200M For Ablynx

No Abstract Read More

FDA OKs TopoTarget's Totect For Extravasation Treatment

Other News To Note

BioAlliance Launches Loramyc; Pleased With Pricing Directive

Business and Academia Merge In UK-Australia Partnership

UK Opens Door to Work With Hybrid Embryos

LONDON - The UK regulator has agreed to the generation of human/animal hybrid embryos for stem cell research, paving the way for it to consider two applications for licenses to conduct such research. (BioWorld International) Read More

MediGene Gets $21M In Private Share Placement

Today's news in brief

BioWorld

BioWorld briefs for March 6, 2026.

Microscopic image of clear cell carcinoma, the most common type of renal cell carcinoma.

Cas and effect: Merck’s phase III ripples HIF-2α space

BioWorld

Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 3, 2026

Tanycytes in green capturing tau protein in red.

Brain’s hidden tau-clearing pathway uncovered

BioWorld Science

Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...

Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent

BioWorld Science

Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...